If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
9 Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany Background The impact of pulmonary rehabilitation (PR) on survival in patients ...
BACKGROUND Beta-2 agonists such as salbutamol are used, not only by asthmatic athletes to prevent exercise induced asthma, but also by non-asthmatic athletes as a potentially ergogenic agent. We have ...
1 Cancer Research Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK 2 Division of Epidemiology and Public Health, University of ...
Background Community-acquired pneumonia (CAP) causes considerable morbidity and mortality in adults, particularly in the elderly. Methods Structured searches of PubMed were conducted to identify up-to ...
BACKGROUND An obstructive defect is usual in bronchiectasis, but the pathophysiological basis of airflow obstruction remains uncertain. High resolution computed tomographic (CT) scanning now allows ...
Dr E Hnizdo, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS PB 163, Morgantown, WV 26505, USA BACKGROUND A study was undertaken to establish the chronic effect of ...
1 The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong SAR Correspondence to William B Goggins III, The Jockey Club School of Public Health ...
1 Department of Palliative Medicine, The North London Hospice and Barnet and Chase Farm Hospitals NHS Trust, London N12 8TF, UK 2 Department of Palliative Medicine, Bristol Haematology and Oncology ...
1 Department of Thoracic Surgery, Leeds Teaching Hospitals, Leeds, UK 2 Department of Clinical Oncology, Leeds Teaching Hospitals, Leeds, UK 3 Department of Clinical Oncology Calderdale and ...
Background Compared with cytotoxic chemotherapy, the efficacy and safety of immune checkpoint inhibitors (ICIs) for patients with interstitial lung disease and non-small cell lung cancer (ILD-NSCLC) ...
3 Department of Respiratory Medicine, Middlemore Hospital, South Auckland, New Zealand 4 Department of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand 5 School of Medicine, University of ...